Cargando…

Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease

Aim: More than 5-year clinical outcomes after femoropopliteal (FP) stenting with bare-nitinol stent (BNS) have not yet been unclear. We investigate the long-term patency and mortality following FP stenting with BNS. Methods: This study was a multicenter retrospective study of a prospectively maintai...

Descripción completa

Detalles Bibliográficos
Autores principales: Soga, Yoshimitsu, Takahara, Mitsuyoshi, Iida, Osamu, Suzuki, Kenji, Mori, Shinsuke, Kawasaki, Daizo, Haraguchi, Kazuki, Yamaoka, Terutoshi, Ando, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529373/
https://www.ncbi.nlm.nih.gov/pubmed/34911883
http://dx.doi.org/10.5551/jat.63225
_version_ 1784801477735219200
author Soga, Yoshimitsu
Takahara, Mitsuyoshi
Iida, Osamu
Suzuki, Kenji
Mori, Shinsuke
Kawasaki, Daizo
Haraguchi, Kazuki
Yamaoka, Terutoshi
Ando, Kenji
author_facet Soga, Yoshimitsu
Takahara, Mitsuyoshi
Iida, Osamu
Suzuki, Kenji
Mori, Shinsuke
Kawasaki, Daizo
Haraguchi, Kazuki
Yamaoka, Terutoshi
Ando, Kenji
author_sort Soga, Yoshimitsu
collection PubMed
description Aim: More than 5-year clinical outcomes after femoropopliteal (FP) stenting with bare-nitinol stent (BNS) have not yet been unclear. We investigate the long-term patency and mortality following FP stenting with BNS. Methods: This study was a multicenter retrospective study of a prospectively maintained database. From April 2004 to December 2011, 1824 consecutive patients (2211 limbs) who underwent FP stenting with BNS for de novo lesions were selected and analyzed. Primary endpoint was primary patency which was defined as treated vessel without restenosis and reintervention and its associated factors. Results: The prevalence of diabetes mellitus and dialysis was 60.5% and 23.8%, respectively. Chronic limb-threatening ischemia (CLTI) accounted for 30.8%. Chronic total occlusion (CTO) was found in 52.7%, and lesion length was more than 20 cm in 22.6%. During the median follow-up of 3.8 years (interquartile range, 1.4 to 7.4 years), 1049 cases lost patency, whereas 355 cases were dead without experiencing loss of patency. The primary patency (95% CI) was estimated to be 74.8%, 47.3% and 29.1% at 1-, 5- and 10-year. On multivariate analysis, female sex, age ≥ 80 years, diabetes, dialysis, CLTI, CTO, arterial calcification, long lesion (>20 cm), and small vessel (≤ 4 mm) were the independent predictors of primary patency after FP stenting. In addition, the prognostic impact of age ≥ 80 years, CLTI, and arterial calcification was significantly attenuated afterwards (P<0.05). Conclusions: Ten-year patency after BNS implantation for FP disease has been continuously reducing up to 10 years and the prognostic impact of risk factors was changed over time.
format Online
Article
Text
id pubmed-9529373
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japan Atherosclerosis Society
record_format MEDLINE/PubMed
spelling pubmed-95293732022-10-18 Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease Soga, Yoshimitsu Takahara, Mitsuyoshi Iida, Osamu Suzuki, Kenji Mori, Shinsuke Kawasaki, Daizo Haraguchi, Kazuki Yamaoka, Terutoshi Ando, Kenji J Atheroscler Thromb Original Article Aim: More than 5-year clinical outcomes after femoropopliteal (FP) stenting with bare-nitinol stent (BNS) have not yet been unclear. We investigate the long-term patency and mortality following FP stenting with BNS. Methods: This study was a multicenter retrospective study of a prospectively maintained database. From April 2004 to December 2011, 1824 consecutive patients (2211 limbs) who underwent FP stenting with BNS for de novo lesions were selected and analyzed. Primary endpoint was primary patency which was defined as treated vessel without restenosis and reintervention and its associated factors. Results: The prevalence of diabetes mellitus and dialysis was 60.5% and 23.8%, respectively. Chronic limb-threatening ischemia (CLTI) accounted for 30.8%. Chronic total occlusion (CTO) was found in 52.7%, and lesion length was more than 20 cm in 22.6%. During the median follow-up of 3.8 years (interquartile range, 1.4 to 7.4 years), 1049 cases lost patency, whereas 355 cases were dead without experiencing loss of patency. The primary patency (95% CI) was estimated to be 74.8%, 47.3% and 29.1% at 1-, 5- and 10-year. On multivariate analysis, female sex, age ≥ 80 years, diabetes, dialysis, CLTI, CTO, arterial calcification, long lesion (>20 cm), and small vessel (≤ 4 mm) were the independent predictors of primary patency after FP stenting. In addition, the prognostic impact of age ≥ 80 years, CLTI, and arterial calcification was significantly attenuated afterwards (P<0.05). Conclusions: Ten-year patency after BNS implantation for FP disease has been continuously reducing up to 10 years and the prognostic impact of risk factors was changed over time. Japan Atherosclerosis Society 2022-10-01 2021-12-14 /pmc/articles/PMC9529373/ /pubmed/34911883 http://dx.doi.org/10.5551/jat.63225 Text en 2022 Japan Atherosclerosis Society https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Original Article
Soga, Yoshimitsu
Takahara, Mitsuyoshi
Iida, Osamu
Suzuki, Kenji
Mori, Shinsuke
Kawasaki, Daizo
Haraguchi, Kazuki
Yamaoka, Terutoshi
Ando, Kenji
Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
title Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
title_full Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
title_fullStr Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
title_full_unstemmed Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
title_short Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
title_sort ten-year clinical follow-up following bare-nitinol stent implantation for femoropopliteal artery disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529373/
https://www.ncbi.nlm.nih.gov/pubmed/34911883
http://dx.doi.org/10.5551/jat.63225
work_keys_str_mv AT sogayoshimitsu tenyearclinicalfollowupfollowingbarenitinolstentimplantationforfemoropoplitealarterydisease
AT takaharamitsuyoshi tenyearclinicalfollowupfollowingbarenitinolstentimplantationforfemoropoplitealarterydisease
AT iidaosamu tenyearclinicalfollowupfollowingbarenitinolstentimplantationforfemoropoplitealarterydisease
AT suzukikenji tenyearclinicalfollowupfollowingbarenitinolstentimplantationforfemoropoplitealarterydisease
AT morishinsuke tenyearclinicalfollowupfollowingbarenitinolstentimplantationforfemoropoplitealarterydisease
AT kawasakidaizo tenyearclinicalfollowupfollowingbarenitinolstentimplantationforfemoropoplitealarterydisease
AT haraguchikazuki tenyearclinicalfollowupfollowingbarenitinolstentimplantationforfemoropoplitealarterydisease
AT yamaokaterutoshi tenyearclinicalfollowupfollowingbarenitinolstentimplantationforfemoropoplitealarterydisease
AT andokenji tenyearclinicalfollowupfollowingbarenitinolstentimplantationforfemoropoplitealarterydisease